Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Yarrow Bioscience, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +8 vs. Q1 2025
- Shares held
- 8.10M
- +938.5K (+13.1%) vs. Q1 2025
- Total value
- $13.4M
- +$1.88M (+16.4%) vs. Q1 2025
- New holders
- 15
- 8 more added
- Sold out
- 7
- 12 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 1,370,938 | $2.26M | 0.17% | +1,370,938 | New |
| Citadel Advisors LLC | 1,040,070 | $1.72M | 0.00% | −60,259−5.5% | Reduced |
| Acorn Capital Advisors, LLC | 736,572 | $1.22M | 0.79% | −49,366−6.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 644,134 | $1.06M | 0.00% | +300,000+87.2% | Added |
| DAFNA Capital Management LLC | 636,103 | $1.05M | 0.29% | 00.0% | Unchanged |
| Kennedy Capital Management, Inc. | 570,740 | $941.7K | 0.02% | +570,740 | New |
| Vanguard Group Inc | 496,297 | $818.9K | 0.00% | +20,647+4.3% | Added |
| Palo Alto Investors LP | 445,434 | $735.0K | 0.16% | 00.0% | Unchanged |
| Patient Square Capital LP | 317,033 | $523.1K | 0.19% | +60,000+23.3% | Added |
| Ikarian Capital, LLC | 290,000 | $478.5K | 0.16% | +290,000 | New |
| Exome Asset Management LLC | 208,970 | $344.8K | 0.28% | −253,831−54.8% | Reduced |
| Schonfeld Strategic Advisors LLC | 161,951 | $267.2K | 0.00% | +76,973+90.6% | Added |
| Geode Capital Management, LLC | 133,329 | $220.0K | 0.00% | −161−0.1% | Reduced |
| Jane Street Group, LLC | 124,822 | $206.0K | 0.00% | +124,822 | New |
| Polygon Management Ltd. | 115,384 | $190.4K | 0.03% | +115,384 | New |
| Boothbay Fund Management, LLC | 106,459 | $175.7K | 0.01% | +106,459 | New |
| Squarepoint Ops LLC | 78,474 | $129.5K | 0.00% | +78,474 | New |
| Bridgeway Capital Management, LLC | 76,958 | $127.0K | 0.00% | +25,000+48.1% | Added |
| Prelude Capital Management, LLC | 64,584 | $106.6K | 0.01% | −76,918−54.4% | Reduced |
| Susquehanna International Group, LLP | 57,814 | $95.4K | 0.00% | +52+0.1% | Added |
| XTX Topco Ltd | 56,908 | $93.9K | 0.00% | +23,856+72.2% | Added |
| Staley Capital Advisers Inc | 51,472 | $84.9K | 0.00% | 00.0% | Unchanged |
| Harvest Investment Services, LLC | 51,326 | $84.7K | 0.02% | +51,326 | New |
| BlackRock, Inc. | 44,405 | $73.3K | 0.00% | −38,174−46.2% | Reduced |
| HRT Financial LP | 42,037 | $69.0K | 0.00% | +15,795+60.2% | Added |
| Velan Capital Investment Management LP | 30,000 | $49.5K | 0.05% | +30,000 | New |
| Northern Trust Corp | 23,110 | $38.1K | 0.00% | −861−3.6% | Reduced |
| Raymond James Financial Inc | 22,164 | $36.6K | 0.00% | +22,164 | New |
| Acadian Asset Management LLC | 22,418 | $36.0K | 0.00% | +22,418 | New |
| Commonwealth Equity Services, LLC | 18,298 | $30.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 15,765 | $26.0K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 13,466 | $22.0K | 0.00% | +13,466 | New |
| Renaissance Technologies LLC | 10,543 | $17.4K | 0.00% | −104,600−90.8% | Reduced |
| Corsair Capital Management, L.P. | 10,000 | $16.5K | 0.00% | +10,000 | New |
| Morgan Stanley | 3,411 | $5.63K | 0.00% | −9,400−73.4% | Reduced |
| Tower Research Capital LLC (TRC) | 2,804 | $4.63K | 0.00% | −1,492−34.7% | Reduced |
| Royal Bank of Canada | 2,440 | $4.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,469 | $2.42K | 0.00% | −15,694−91.4% | Reduced |
| MB, Levis & Associates, LLC | 1,041 | $1.72K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Centerpoint Advisors, LLC | 350 | $1.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 146 | $241 | 0.00% | −5,835−97.6% | Reduced |
| Wells Fargo & Company | 65 | $107 | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 25 | $41 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 16 | $26 | 0.00% | +16 | New |
| Northwestern Mutual Wealth Management Co | 11 | $18 | 0.00% | +11 | New |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −1,394,336−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −217,978−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −70,419−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −45,557−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,574−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −18,015−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −7,576−100.0% | Sold out |